Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PI4 metformin for prolongation of gestation in preterm preeclampsia
2022-502707-29-00Phase 3Authorised
- Sponsor
- Region Västra Götaland
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia comparing Metformin with Placebo (2 arms). Primary endpoint: Prolongation of gestation. Planned start Feb 2024; status: authorised.
02
Drugs
metformin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on 2022-502707-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502707-29-00.